Fabscout Entertainment, Inc recalls Clalis capsules, 50 mg, 6 -count bottle ( labeling is in foreign language)
Recalled March 26, 2014 · FDA recall D-1169-2014 · Fabscout Entertainment
Hazard
Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined that the products was found to contain sildenafil, an undeclared active pharmaceutical ingredient. · FDA Class I
Sold at
Nationwide and France
Description
Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined that the products was found to contain sildenafil, an undeclared active pharmaceutical ingredient.
Product
Clalis capsules, 50 mg, 6 -count bottle ( labeling is in foreign language)
Manufacturer(s)
Fabscout Entertainment, Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →